Chicago Capital, LLC Dexcom Inc Transaction History

Chicago Capital, LLC

$3.56 Billion
Q3 2024

A detailed history of Chicago Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Chicago Capital, LLC holds 483,779 shares of DXCM stock, worth $38.8 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

483,779

Previous 677,324 28.57%

Holding current value

$38.8 Million

Previous $76.8 Million 57.78%

% of portfolio

0.91%

Previous 2.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$64.0 - $116.06 $12.4 Million - $22.5 Million	-193,545 Reduced 28.57%	483,779 $32.4 Million
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $203,191 - $258,708	1,842 Added 0.27%	677,324 $76.8 Million
Q1 2024 Apr 15, 2024	SELL	$114.22 - $140.1 $194,859 - $239,010	-1,706 Reduced 0.25%	675,482 $93.7 Million
Q4 2023 Jan 22, 2024	BUY	$75.49 - $124.16 $3.26 Million - $5.36 Million	43,161 Added 6.81%	677,188 $84 Million
Q3 2023 Oct 25, 2023	BUY	$86.06 - $137.93 $2.49 Million - $3.99 Million	28,927 Added 4.78%	634,027 $59.2 Million
Q2 2023 Jul 20, 2023	BUY	$112.47 - $130.98 $2.5 Million - $2.92 Million	22,256 Added 3.82%	605,100 $77.8 Million
Q1 2023 Apr 18, 2023	SELL	$104.0 - $122.92 $243,048 - $287,264	-2,337 Reduced 0.4%	582,844 $67.7 Million
Q4 2022 Jan 20, 2023	SELL	$84.98 - $122.67 $583,302 - $842,006	-6,864 Reduced 1.16%	585,181 $0
Q3 2022 Oct 14, 2022	SELL	$76.35 - $94.18 $2.01 Million - $2.47 Million	-26,261 Reduced 4.25%	592,045 $47.7 Million
Q2 2022 Jul 21, 2022	BUY	$67.99 - $132.89 $31.5 Million - $61.6 Million	463,370 Added 299.07%	618,306 $46.1 Million
Q1 2022 Apr 21, 2022	BUY	$94.08 - $130.2 $763,082 - $1.06 Million	8,111 Added 5.52%	154,936 $79.3 Million
Q4 2021 Jan 20, 2022	SELL	$129.87 - $162.82 $422,337 - $529,490	-3,252 Reduced 2.17%	146,825 $78.8 Million
Q3 2021 Oct 28, 2021	SELL	$106.71 - $143.18 $211,285 - $283,496	-1,980 Reduced 1.3%	150,077 $82.1 Million
Q2 2021 Jul 22, 2021	SELL	$80.99 - $107.93 $185,143 - $246,727	-2,286 Reduced 1.48%	152,057 $64.9 Million
Q1 2021 Apr 13, 2021	BUY	$84.79 - $104.74 $422,762 - $522,233	4,986 Added 3.34%	154,343 $55.5 Million
Q4 2020 Jan 25, 2021	BUY	$78.0 - $104.5 $704,106 - $943,321	9,027 Added 6.43%	149,357 $55.2 Million
Q3 2020 Oct 13, 2020	SELL	$95.51 - $112.95 $2.46 Million - $2.91 Million	-25,793 Reduced 15.53%	140,330 $57.8 Million
Q2 2020 Jul 29, 2020	SELL	$62.68 - $105.34 $605,551 - $1.02 Million	-9,661 Reduced 5.5%	166,123 $67.3 Million
Q1 2020 Apr 21, 2020	SELL	$47.79 - $75.63 $786,193 - $1.24 Million	-16,451 Reduced 8.56%	175,784 $47.3 Million
Q4 2019 Jan 14, 2020	SELL	$36.62 - $57.29 $122,274 - $191,291	-3,339 Reduced 1.71%	192,235 $42 Million
Q3 2019 Oct 29, 2019	BUY	$35.53 - $43.8 $32,012 - $39,463	901 Added 0.46%	195,574 $29.2 Million
Q2 2019 Jul 11, 2019	BUY	$27.84 - $38.92 $65,618 - $91,734	2,357 Added 1.23%	194,673 $29.2 Million
Q1 2019 Apr 23, 2019	SELL	$28.07 - $38.18 $25,655 - $34,896	-914 Reduced 0.47%	192,316 $22.9 Million
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $17,705 - $24,514	-656 Reduced 0.34%	193,230 $23.1 Million
Q3 2018 Nov 02, 2018	SELL	$23.35 - $36.72 $1.05 Million - $1.65 Million	-44,973 Reduced 18.83%	193,886 $27.7 Million
Q2 2018 Jul 19, 2018	BUY	$17.54 - $25.22 $1.45 Million - $2.08 Million	82,646 Added 52.91%	238,859 $22.7 Million
Q1 2018 May 09, 2018	BUY	$13.06 - $18.54 $2.04 Million - $2.9 Million	156,213 New	156,213 $11.6 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Dexcom Inc Transaction History